Related Experiment Video
Updated: Aug 7, 2026

08:47
Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
Published on: March 3, 2023
Leveraging machine learning models to forecast pediatric allergic rhinitis exacerbation risk based on environmental
Zhicheng Li1, Shan Huang1, Zhongfang Xia1
1Department of Otolaryngology, Wuhan Children's Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Frontiers in Pediatrics
|August 6, 2026
Summary
Predicting pediatric allergic rhinitis (AR) exacerbations is challenging. A machine learning model integrating symptom scores and PM2.5 exposure shows promise for predicting AR exacerbations in children.
Area of Science:
- Environmental Health
- Pediatric Allergy
- Machine Learning in Medicine
Background:
- Acute exacerbations of pediatric allergic rhinitis (AR) lack reliable prediction tools.
- Individualized risk assessment integrating clinical and environmental data is needed.
Purpose of the Study:
- To develop an interpretable machine learning model for predicting 90-day AR exacerbation risk in children.
- To conduct a preliminary assessment of the model's transportability to an independent cohort.
Main Methods:
- A development cohort (n=2,000) linked NHANES, EPA Air Quality, and NOAA data.
- Clinical predictors (TNSS, IgE, eosinophils) and environmental exposures (PM2.5, PM10, O3, NO2, temp, humidity) were analyzed.
- L2-regularized logistic regression (LR) was the primary model, benchmarked against other ML algorithms using cross-validation and multiple imputation.
Main Results:
- The LR model achieved an internal AUC of 0.81 and external AUC of 0.71.
- Key predictors included Total Nasal Symptom Score (TNSS), same-day PM2.5, and total IgE.
- Children exposed to high PM2.5 (>75 μg/m3) had ~5x higher exacerbation odds (OR=5.08).
Conclusions:
- An interpretable LR model combining symptom burden and PM2.5 exposure shows potential for predicting pediatric AR exacerbations.
- Preliminary findings suggest model transportability, but a small external cohort limits definitive validation.
- Larger prospective studies are needed for clinical implementation.